AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · IEX Real-Time Price · USD
0.398
-0.006 (-1.58%)
May 3, 2024, 9:52 AM EDT - Market open
AIM ImmunoTech Revenue
In the year 2023, AIM ImmunoTech had annual revenue of $202.00K with 43.26% growth. Revenue in the quarter ending December 31, 2023 was $65.00K with 16.07% year-over-year growth.
Revenue (ttm)
$202.00K
Revenue Growth
+43.26%
P/S Ratio
99.85
Revenue / Employee
$7,769
Employees
26
Market Cap
19.93M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 202.00K | 61.00K | 43.26% |
Dec 31, 2022 | 141.00K | 6.00K | 4.44% |
Dec 31, 2021 | 135.00K | -28.00K | -17.18% |
Dec 31, 2020 | 163.00K | 23.00K | 16.43% |
Dec 31, 2019 | 140.00K | -227.00K | -61.85% |
Dec 31, 2018 | 367.00K | -70.00K | -16.02% |
Dec 31, 2017 | 437.00K | 345.00K | 375.00% |
Dec 31, 2016 | 92.00K | -41.00K | -30.83% |
Dec 31, 2015 | 133.00K | -64.00K | -32.49% |
Dec 31, 2014 | 197.00K | 47.00K | 31.33% |
Dec 31, 2013 | 150.00K | -63.00K | -29.58% |
Dec 31, 2012 | 213.00K | 52.00K | 32.30% |
Dec 31, 2011 | 161.00K | 26.00K | 19.26% |
Dec 31, 2010 | 135.00K | 24.00K | 21.62% |
Dec 31, 2009 | 111.00K | -154.00K | -58.11% |
Dec 31, 2008 | 265.00K | -794.00K | -74.98% |
Dec 31, 2007 | 1.06M | 126.00K | 13.50% |
Dec 31, 2006 | 933.00K | -150.00K | -13.85% |
Dec 31, 2005 | 1.08M | -146.00K | -11.88% |
Dec 31, 2004 | 1.23M | 572.00K | 87.06% |
Dec 31, 2003 | 657.00K | -247.00K | -27.32% |
Dec 31, 2002 | 904.00K | 514.00K | 131.79% |
Dec 31, 2001 | 390.00K | -398.00K | -50.51% |
Dec 31, 2000 | 788.00K | 110.00K | 16.22% |
Dec 31, 1999 | 678.00K | 277.00K | 69.08% |
Dec 31, 1998 | 401.00K | 142.29K | 55.00% |
Dec 31, 1997 | 258.72K | 226.67K | 707.37% |
Dec 31, 1996 | 32.04K | -2.93M | -98.92% |
Dec 31, 1995 | 2.97M | 2.79M | 1,587.50% |
Dec 31, 1994 | 175.76K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Flora Growth | 76.07M |
MEI Pharma | 72.65M |
Accelerate Diagnostics | 12.06M |
T2 Biosystems | 7.19M |
PAVmed | 2.45M |
BioSig Technologies | 18.00K |
AIM News
- 4 days ago - AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer - GlobeNewsWire
- 8 days ago - AIM ImmunoTech Announces Release of the Next CEO Corner Segment - GlobeNewsWire
- 18 days ago - AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs - GlobeNewsWire
- 23 days ago - AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer - GlobeNewsWire
- 4 weeks ago - AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research - GlobeNewsWire